Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists.

Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists.

Item
http://www.wikidata.org/entity/Q36099400
Computational methods in drug discoveryDual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsHistamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibilityTherapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS.Proxyfan acts as a neutral antagonist of histamine H3 receptors in the feeding-related hypothalamic ventromedial nucleus.Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas.H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice.The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetesRecent advances in the development of histamine H3 antagonists.Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.Central histaminergic system interplay with suppressive effects of immune challenge on food intake in chicken.Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.The effect of Nesfatin-1 on food intake in neonatal chicks: role of CRF1 /CRF2 and H1/ H3 receptors.
P2860

Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists.

Item
http://www.wikidata.org/entity/Q36099400
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Assessment of pharmacology and ...... antagonists/inverse agonists.
@ast
Assessment of pharmacology and ...... antagonists/inverse agonists.
@en
type
label
Assessment of pharmacology and ...... antagonists/inverse agonists.
@ast
Assessment of pharmacology and ...... antagonists/inverse agonists.
@en
prefLabel
Assessment of pharmacology and ...... antagonists/inverse agonists.
@ast
Assessment of pharmacology and ...... antagonists/inverse agonists.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Assessment of pharmacology and ...... antagonists/inverse agonists.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921